WO2012065680A3 - Dihydroxyfumarsäure-derivate und deren verwendung zur hautaufhellung - Google Patents

Dihydroxyfumarsäure-derivate und deren verwendung zur hautaufhellung Download PDF

Info

Publication number
WO2012065680A3
WO2012065680A3 PCT/EP2011/005330 EP2011005330W WO2012065680A3 WO 2012065680 A3 WO2012065680 A3 WO 2012065680A3 EP 2011005330 W EP2011005330 W EP 2011005330W WO 2012065680 A3 WO2012065680 A3 WO 2012065680A3
Authority
WO
WIPO (PCT)
Prior art keywords
acid derivatives
dihydroxyfumaric acid
skin
bleaching skin
bleaching
Prior art date
Application number
PCT/EP2011/005330
Other languages
English (en)
French (fr)
Other versions
WO2012065680A2 (de
Inventor
René Peter SCHEURICH
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Priority to EP11781435.0A priority Critical patent/EP2640348A2/de
Priority to JP2013539153A priority patent/JP2013542964A/ja
Priority to CN2011800546570A priority patent/CN103269677A/zh
Priority to US13/988,112 priority patent/US20130266526A1/en
Priority to KR1020137015668A priority patent/KR20130129221A/ko
Publication of WO2012065680A2 publication Critical patent/WO2012065680A2/de
Publication of WO2012065680A3 publication Critical patent/WO2012065680A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die vorliegende Erfindung betrifft die Verwendung von Dihydroxyfumarsäure-Derivaten zur Aufhellung der Haut, zur Hemmung von Tyrosinase und zur Prophylaxe, Behandlung und/oder Verlaufskontrolle von Pigmentstörungen der Haut, sowie kosmetische und dermatologische Zubereitungen und Arzneimittel enthaltend Dihydroxyfumarsäure-Derivate und neue Dihydroxyfumarsäure-Derivate.
PCT/EP2011/005330 2010-11-17 2011-10-21 Dihydroxyfumarsäure-derivate und deren verwendung zur hautaufhellung WO2012065680A2 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP11781435.0A EP2640348A2 (de) 2010-11-17 2011-10-21 Dihydroxyfumarsäure-derivate und deren verwendung zur hautaufhellung
JP2013539153A JP2013542964A (ja) 2010-11-17 2011-10-21 ジヒドロキシフマル酸誘導体および皮膚美白のためのその使用
CN2011800546570A CN103269677A (zh) 2010-11-17 2011-10-21 二羟基富马酸衍生物及其用于使皮肤增白的用途
US13/988,112 US20130266526A1 (en) 2010-11-17 2011-10-21 Dihydroxyfumaric acid derivatives and the use thereof for skin lightening
KR1020137015668A KR20130129221A (ko) 2010-11-17 2011-10-21 디히드록시푸마르산 유도체 및 피부 미백을 위한 이의 용도

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010051689A DE102010051689A1 (de) 2010-11-17 2010-11-17 Dihydroxyfumarsäure-Derivate und deren Verwendung zur Hautaufhellung
DE102010051689.9 2010-11-17

Publications (2)

Publication Number Publication Date
WO2012065680A2 WO2012065680A2 (de) 2012-05-24
WO2012065680A3 true WO2012065680A3 (de) 2013-06-27

Family

ID=44925477

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/005330 WO2012065680A2 (de) 2010-11-17 2011-10-21 Dihydroxyfumarsäure-derivate und deren verwendung zur hautaufhellung

Country Status (7)

Country Link
US (1) US20130266526A1 (de)
EP (1) EP2640348A2 (de)
JP (1) JP2013542964A (de)
KR (1) KR20130129221A (de)
CN (1) CN103269677A (de)
DE (1) DE102010051689A1 (de)
WO (1) WO2012065680A2 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1514216A (en) * 1974-07-18 1978-06-14 Nelson Res & Dev Microbiocidal composition
EP0313303A2 (de) * 1987-10-22 1989-04-26 The Procter & Gamble Company Tocopherolsorbat und entzündungshemmende Wirkstoffe enthaltende Lichtschutzmittel
WO2001066105A1 (en) * 2000-03-07 2001-09-13 Young Pharmaceuticals, Inc. Method and composition for lightening the skin

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52110055A (en) * 1976-03-11 1977-09-14 Nelson Res & Dev Contact lens preserve solution
US4847069A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
JP2564690B2 (ja) * 1990-06-14 1996-12-18 三省製薬 株式会社 メラニン生成抑制外用剤
TW197375B (de) 1990-11-19 1993-01-01 Hayashibara Biochem Lab
FR2680683B1 (fr) 1991-08-29 1993-11-12 Oreal Composition cosmetique filtrante contenant un polymere filtre a structure hydrocarbonee et une silicone filtre.
FR2735688B1 (fr) * 1995-06-26 1997-08-14 Oreal Utilisation en association d'un alpha-hydroxyacide et d'un oxyde de titane pour le blanchiment de la peau
CZ290351B6 (cs) * 1996-11-04 2002-07-17 The Procter & Gamble Company Kosmetický prostředek pro zesvětlení pokoľky, způsob zesvětlení pokoľky u savců a způsob přípravy tohoto kosmetického prostředku
US5776473A (en) 1997-01-17 1998-07-07 Warner-Lambert Company Razor comfort strip with alpha-hydroxy acid additive
US6472432B1 (en) * 1997-11-17 2002-10-29 Nicholas V. Perricone Treatment of rosacea using lipoic acid
DE10133202A1 (de) 2001-07-07 2003-01-16 Beiersdorf Ag Osmolyte enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
JP2004123544A (ja) * 2002-09-30 2004-04-22 Fuji Photo Film Co Ltd ４，５−ジアルコキシカルボニルイミダゾール化合物の製造方法
DE10337863A1 (de) 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
US20060110415A1 (en) 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
EP1871339A1 (de) 2005-04-19 2008-01-02 Merck Patent GmbH Uv schutz

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1514216A (en) * 1974-07-18 1978-06-14 Nelson Res & Dev Microbiocidal composition
EP0313303A2 (de) * 1987-10-22 1989-04-26 The Procter & Gamble Company Tocopherolsorbat und entzündungshemmende Wirkstoffe enthaltende Lichtschutzmittel
WO2001066105A1 (en) * 2000-03-07 2001-09-13 Young Pharmaceuticals, Inc. Method and composition for lightening the skin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RAVINDRA P. PATEL ET AL: "INABILITY OF MURINE MELANOMA "TYROSINASE" (DOPA OXIDASE) TO OXIDIZE TYROSINE IN THE PRESENCE OR ABSENCE OF DOPA OR DIHYDROXYFUMARATE COFACTOR.", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 61, no. 2, August 1973 (1973-08-01), pages 55 - 59, XP055059320, ISSN: 0022-202X, DOI: 10.1111/1523-1747.ep12674766 *

Also Published As

Publication number Publication date
KR20130129221A (ko) 2013-11-27
JP2013542964A (ja) 2013-11-28
DE102010051689A1 (de) 2012-05-24
WO2012065680A2 (de) 2012-05-24
CN103269677A (zh) 2013-08-28
EP2640348A2 (de) 2013-09-25
US20130266526A1 (en) 2013-10-10

Similar Documents

Publication Publication Date Title
WO2009012871A3 (de) Uv-filter-kapsel
PL2758381T3 (pl) PREPARATY KOSMETYCZNE LUB DERMATOLOGICZNE ZAWIERAJĄCE AMIDOTIAZOLE ALKILOWE I ICH STOSOWANIE W CELU USUWANIA NIEPOŻĄDANYCH PRZEBARWIEŃ SKÓRY i ZAPOBIEGANIA ICH POWSTAWANIU
WO2012030984A3 (en) Skin compositions and methods of use thereof
WO2006087759A3 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid
PL2758383T3 (pl) Preparaty kosmetyczne lub dermatologiczne zawierające amidotiazole aromatyczne i ich stosowanie do usuwania niepożądanych przebarwień skóry i zapobiegania ich powstawaniu
WO2009125925A3 (ko) 성장인자―미미킹 펩타이드 및 그의 용도
WO2014012075A3 (en) Treating hair loss and delaying aging of skin
WO2012076109A3 (de) 2-pyrone
ATE530226T1 (de) Verwendung von sinapinsäure in nicht- therapeutischen kosmetischen und/oder topischen zubereitungen
WO2013174774A3 (en) Cosmetic compositions comprising magnetosomes and uses thereof
WO2012116990A3 (en) Novel use
BR112012032877A2 (pt) uso de ácido chicórico e derivados para regulagem de pigmentação da pele
PT2352493E (pt) Utilização terapêutica, dietética ou cosmética de compostos com atividade anti-apoptótica específica para a caspase-3 e composições contendo esses compostos
WO2013030794A3 (en) Use of substituted pyridines as skin depigmenting compounds
WO2013060707A3 (de) Kosmetische mittel enthaltend oxytocin und riechstoffe
MX345695B (es) Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.
WO2007113531A3 (en) Topical drug delivery
WO2011079971A3 (de) Kosmetische mittel, enthaltend euk-134 und/oder euk-118 und mindestens einen pflegestoff
MX2009012712A (es) Nuevas 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
MX2009012714A (es) Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
WO2010130776A3 (en) Use of delta-tocopheryl-carbohydrate as a depigmenting agent
WO2009138513A3 (en) Mesoporous vector containing at least one organic uv filter.
WO2013087665A3 (en) Composition comprising a carboxylated fructan for epidermis hydratation
IL192971A0 (en) Use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders, and cosmetic or pharmaceutical composition containing same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11781435

Country of ref document: EP

Kind code of ref document: A2

REEP Request for entry into the european phase

Ref document number: 2011781435

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011781435

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2013539153

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13988112

Country of ref document: US

ENP Entry into the national phase

Ref document number: 20137015668

Country of ref document: KR

Kind code of ref document: A